Results 101 to 110 of about 27,057 (223)

Primary myelofibrosis: spectrum of imaging features and disease-related complications

Insights into Imaging, 2019
Primary myelofibrosis is a chronic clonal stem cell disorder that results in a build-up of marrow fibrosis and dysfunction, hypermetabolic states, and myeloid metaplasia.
Sheng Fei Oon, Dalveer Singh, Teng Han Tan, Allan Lee, Geertje Noe, Kate Burbury, Joseph Paiva   +6 more
doaj   +1 more source

Leucoerythroblastic PICTURE and Bone Marrow Fibrosis: Infantile Primary Myelofibrosis

Hematology/Oncology and Stem Cell Therapy, 2022
Hasan Hashem, Nazmi Kamal
doaj   +1 more source

Coexistence of primary myelofibrosis and chronic lymphocytic leukemia

Blood and Lymphatic Cancer: Targets and Therapy, 2014
Sonja Burgstaller, Josef Thaler Klinikum Wels-Grieskirchen, Abteilung für Innere Medizin IV, Wels, AustriaAbstract: Coexistence of two hematologic malignancies in one patient is generally a rare phenomenon.
Burgstaller S, Thaler J
doaj  

CD34-positive circulating cells quantification during follow-up in myeloproliferative neoplasms

Annals of Hematology
Polycythemia vera (PV) and Essential thrombcythemia (ET) are myeloproliferative neoplasms (MPNs) that can progress to secondary myelofibrosis, a complication associated with increased mortality. Circulating CD34-positive cells at diagnosis can be used to
Marine Demoy, Maxence Bauvais, Agathe Vely, Thomas Nicol, Jérémie Riou, Hortense Le Jeanne, Aurélien Bauduin, Hubert Rambaud, Françoise Boyer, Franck Geneviève, Agathe Boussaroque, Marie-Christine Copin, Valérie Ugo, Corentin Orvain, Damien Luque Paz   +14 more
doaj   +1 more source

Retroperitoneal extramedullary hematopoietic pseudotumor in ataxia-telangiectasia. [PDF]

, 2018
Ataxia-telangiectasia confers a significant increase in the development of several cancer types, most commonly leukemia and lymphoma. However, as the natural history for these patients is evolving and their lifespan is increasing, there is the potential ...
Bateni, Cyrus P, Canter, Robert J, Darrow, Morgan A, Evans, Christopher P, Judge, Sean James, Plescia, Trevor A   +5 more
core  

JAK-2 inhibitors and allogeneic transplant in myelofibrosis [PDF]

, 2015
7The activation of the JAK1/JAK2 pathway plays a crucial role in the pathogenesis of myelofibrosis. Treatment with the JAK2 inhibitor ruxolitinib demonstrated to reduce splenomegaly and symptoms in patients affected by myelofibrosis, leading to a ...
Cigana, C, De Marchi, R, Fanin, Renato, Lazzarotto, D, Patriarca, Francesca, Perali, G, Sperotto, A   +6 more
core  

Primary myelofibrosis L.

Онкогематология, 2014
Literature data of idiopathic myelofibrosis are presented: classification, diagnostic criteria, morphological and molecular features. Particular attention is given to therapy of various clinical forms of primary myelofibrosis.
L. M. Meshcheryakova, O. V. Porotkova, L. G. Kovaleva, L. Yu. Kolosova, S. N. Bychkova   +4 more
openaire   +2 more sources

Primary myelofibrosis: risk stratification by IPSS identifies patients with poor clinical outcome

Clinics, 2013
OBJECTIVES: To evaluate whether risk scores used to classify patients with primary myelofibrosis and JAK-2 V617F mutation status can predict clinical outcome.
Bruno Deltreggia Benites, Carolina Silva Costa Lima, Irene Lorand-Metze, Marcia Torresan Delamain, Gislaine Borba Oliveira, Daiane de Almeida, Carmino Antonio de Souza, Jose Vassallo, Katia Borgia Barbosa Pagnano   +8 more
doaj  

Biomolecular and histological features in pediatric essential thrombocythemia: adequacy of who diagnostic criteria [PDF]

, 2017
Myeloproliferative neoplasms (MPN), Essential Thrombocythemia (ET), Polycythemia Vera (PV) and primary myelofibrosis (PMF), are clonal disorders of the hematopoietic stem cell.
Bertozzi, Irene
core   +1 more source

Fibrocytes in primary myelofibrosis

Oncotarget, 2021
Shimoda, Kazuya, Ozono, Yoshinori, Shide, Kotaro   +2 more
openaire   +2 more sources